Results of the c-trak tn trial: a clinical trial utilising ctdna mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

HIGHLIGHTS

• who: N.C. Turner from the Marsden Hospital, LondonPathology, Marsden Hospital, London have published the Article: Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer, in the Journal: (JOURNAL) of 19/03/2020
• what: The authors designed the c-TRAK TN trial to establish the potential for ctDNA-guided therapy, and it is to the knowledge the first prospective study to assess whether ctDNA assays have clinical utility in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.